The NF-κB Pharmacopeia: Novel Strategies to Subdue an Intractable Target
NF-κB transcription factors are major drivers of tumor initiation and progression. NF-κB signaling is constitutively activated by genetic alterations or environmental signals in many human cancers, where it contributes to almost all hallmarks of malignancy, including sustained proliferation, cell de...
Main Authors: | Daniela Verzella, Jessica Cornice, Paola Arboretto, Davide Vecchiotti, Mauro Di Vito Nolfi, Daria Capece, Francesca Zazzeroni, Guido Franzoso |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/9/2233 |
Similar Items
-
NF-κB: Governing Macrophages in Cancer
by: Jessica Cornice, et al.
Published: (2024-01-01) -
NF-κB: A Druggable Target in Acute Myeloid Leukemia
by: Barbara Di Francesco, et al.
Published: (2022-07-01) -
Elevated NF-κB/SHh/GLI1 Signature Denotes a Worse Prognosis and Represent a Novel Potential Therapeutic Target in Advanced Prostate Cancer
by: Davide Vecchiotti, et al.
Published: (2022-07-01) -
EV-Mediated Chemoresistance in the Tumor Microenvironment: Is NF-κB a Player?
by: Mauro Di Vito Nolfi, et al.
Published: (2022-06-01) -
At the crossroads of SUMO and NF-κB
by: Schmidt Christian, et al.
Published: (2003-11-01)